FilingsTodayOmega Healthcare Investors
At a glance
Omega Healthcare Investors reported 2025 revenue of $1.19B, up 13.2% from $1.05B in 2024. Over 4 years since 2021 ($1.06B), that is growth of about 2.9% a year. 2025 was the highest revenue year in this period.
In the last 12 months 2 insiders reported 2 open-market purchases ($1.4M) and 0 sales. The largest was a purchase of $863K by CHIEF EXECUTIVE OFFICER C Taylor Pickett on Nov 6, 2025.
Omega Healthcare Investors filed 9 current reports (Form 8-K) in the last 12 months, most often for officer or director change (3), results of operations (3), regulation fd disclosure (1) and shareholder vote results (1). The latest officer or director change was reported on Oct 1, 2026.
1 of the 20 investors tracked here held Omega Healthcare Investors at the last quarter end, worth $2.9M combined. It is the largest weight for Renaissance Technologies (0% of its portfolio). Reduced: Renaissance Technologies.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $428K | $439K | $249K | $418K | $609K |
| Diluted EPS | $1.75 | $1.80 | $1.00 | $1.55 | $1.94 |
| Dividend per share | $2.68 | $2.68 | $2.68 | $2.68 | $2.68 |
Fiscal year ends Dec 31 · incorporated in MD
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined